Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
Psychopharmacology
|
January 1, 1992
Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride
L Farde
Trends in Neurosciences
|
June 1, 1996
The advantage of using positron emission tomography in drug research
L Farde
Schizophrenia Research
|
February 19, 1998
Brain imaging of schizophrenia--the dopamine hypothesis
L Farde
Lakartidningen
|
November 28, 1984
[Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases]
L Farde, G Sedvall
Psychopharmacology
|
February 9, 2000
Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies
S Nyberg, L Farde
Scandinavian Journal of Psychology
|
August 15, 2001
Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging
L Bäckman, L Farde
Lancet (London, England)
|
September 16, 1995
Chemical brain anatomy in schizophrenia
G Sedvall, L Farde
Journal of Psychopharmacology (Oxford, England)
|
January 1, 1997
The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed
S Nyberg, L Farde
Lancet (London, England)
|
January 27, 1996
Dopamine receptors in schizophrenia
G Sedvall, L Farde
Arzneimittel-Forschung
|
February 1, 1992
Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands
L Farde, H Hall
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
Psychopharmacology
|
January 1, 1992
Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride
L Farde
Trends in Neurosciences
|
June 1, 1996
The advantage of using positron emission tomography in drug research
L Farde
Schizophrenia Research
|
February 19, 1998
Brain imaging of schizophrenia--the dopamine hypothesis
L Farde
Lakartidningen
|
November 28, 1984
[Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases]
L Farde, G Sedvall
Psychopharmacology
|
February 9, 2000
Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies
S Nyberg, L Farde
Scandinavian Journal of Psychology
|
August 15, 2001
Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging
L Bäckman, L Farde
Lancet (London, England)
|
September 16, 1995
Chemical brain anatomy in schizophrenia
G Sedvall, L Farde
Journal of Psychopharmacology (Oxford, England)
|
January 1, 1997
The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed
S Nyberg, L Farde
Lancet (London, England)
|
January 27, 1996
Dopamine receptors in schizophrenia
G Sedvall, L Farde
Arzneimittel-Forschung
|
February 1, 1992
Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands
L Farde, H Hall
Page
of 21